000 01170 a2200325 4500
005 20250518091218.0
264 0 _c20210309
008 202103s 0 0 eng d
022 _a1365-2141
024 7 _a10.1111/bjh.16564
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVarghese, Abraham M
245 0 0 _aCurrent pricing model for cancer drugs - is it 'Justum Pretium' for the developing world? Taking management of chronic lymphocytic leukaemia in India into consideration.
_h[electronic resource]
260 _bBritish journal of haematology
_c09 2020
300 _ae292-e294 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAged
650 0 4 _aAntineoplastic Agents
_xeconomics
650 0 4 _aCosts and Cost Analysis
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIndia
650 0 4 _aLeukemia, Lymphocytic, Chronic, B-Cell
_xdrug therapy
650 0 4 _aMale
650 0 4 _aModels, Economic
700 1 _aSood, Nitin
700 1 _aDaniel, Sunitha M
773 0 _tBritish journal of haematology
_gvol. 190
_gno. 5
_gp. e292-e294
856 4 0 _uhttps://doi.org/10.1111/bjh.16564
_zAvailable from publisher's website
999 _c30720821
_d30720821